and its side effects
AstraZeneca informed the FDA of a study involving 1,700 lung cancer patients:
1. Patients who took Iressa lived for 5.6 months.
2. Those given a placebo (inactive, dummy pill) lived for 5.1 months.
The study shows by taking Iressa, patients live longer by TWO weeks. As a result, Iressa was withdrawn in Western countries. However, patients of Asian origin responded slightly better. They lived FOUR months longer.
1. With Iressa lung cancer patients lived 9.5 months.
2. Without Iressa patients lived only ...Read More →